Clinical Research Directory
Browse clinical research sites, groups, and studies.
Alb-PRF as an Adjunct to Nonsurgical Periodontal Therapy
Sponsor: Halil Ata BIÇAKÇIOĞLU
Summary
Periodontitis is an inflammatory disease that damages the tissues supporting the teeth. Nonsurgical periodontal therapy is the standard initial treatment, but deep periodontal pockets may remain after treatment. Albumin platelet-rich fibrin (Alb-PRF) is an autologous material prepared from the participant's own blood and applied locally to support periodontal healing. The main purpose of this study is to determine whether applying Alb-PRF into periodontal pockets in addition to nonsurgical periodontal therapy provides greater clinical improvement than nonsurgical periodontal therapy alone. The study will also evaluate whether the additional application of Alb-PRF affects the levels of selected bacteria associated with periodontitis. This randomized split-mouth study will include 24 adults with periodontitis. In each participant, matched periodontal sites will be randomly assigned to receive either nonsurgical periodontal therapy alone or nonsurgical periodontal therapy followed by an intrapocket application of Alb-PRF. Clinical periodontal measurements will be recorded at baseline and at 1, 3, and 6 months. Subgingival plaque samples will be collected from the same sites at baseline and 30 days after treatment. The primary outcome is the reduction in periodontal probing depth from baseline to 3 months.
Official title: Clinical and Microbiological Effects of Intrapocket Albumin Platelet-Rich Fibrin as an Adjunct to Nonsurgical Periodontal Therapy: A Randomized Split-Mouth Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-12-01
Completion Date
2027-12-01
Last Updated
2026-08-31
Healthy Volunteers
No
Conditions
Interventions
Nonsurgical Periodontal Therapy
Nonsurgical periodontal therapy will include individualized oral hygiene instruction and supra- and subgingival mechanical debridement using periodontal hand instruments and/or ultrasonic devices. This intervention will be administered to the periodontal sites assigned to both study arms.
Albumin Platelet-Rich Fibrin
Alb-PRF will be prepared under sterile conditions from autologous venous blood collected from each participant during the treatment visit. The albumin-containing plasma fraction will be heated at 75°C for 10 minutes and then combined with the appropriate liquid platelet-rich fibrin fraction to produce the Alb-PRF matrix. The freshly prepared Alb-PRF will be applied locally into the periodontal pocket immediately after nonsurgical periodontal therapy.
Locations (2)
Gazi University Faculty of Dentistry, Department of Periodontology
Ankara, Ankara, Turkey (Türkiye)
Çankırı Karatekin University Faculty of Dentistry, Department of Periodontology
Çankırı, Çankırı, Turkey (Türkiye)